Clover Health Investments (CLOV) Liabilities and Shareholders Equity (2019 - 2026)

Clover Health Investments (CLOV) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $697.7 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 19.53% year-over-year to $697.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 billion (up 17.09% YoY) and the FY2025 annual result came in at $541.0 million, down 6.84% from the prior year.
• Liabilities and Shareholders Equity climbed to $697.7 million in Q1 2026, from $541.0 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.7 billion in Q1 2022 to a low of $354.7 million in Q4 2022.
• A 5-year average of $838.2 million and a median of $580.7 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity surged 209.12% — and 2023, when it slumped 72.48%.
• Tracing CLOV's Liabilities and Shareholders Equity over 5 years: stood at $354.7 million in 2022, then jumped by 60.87% to $570.7 million in 2023, then advanced by 1.76% to $580.7 million in 2024, then fell by 6.84% to $541.0 million in 2025, then climbed by 28.97% to $697.7 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $697.7 million (Q1 2026), $541.0 million (Q4 2025), and $559.7 million (Q3 2025), per Business Quant data.